SE386903B - Forfarande for framstellning av beta-11-klorsubstituerade steroider tillhorande pregnanserien - Google Patents

Forfarande for framstellning av beta-11-klorsubstituerade steroider tillhorande pregnanserien

Info

Publication number
SE386903B
SE386903B SE7208742A SE874272A SE386903B SE 386903 B SE386903 B SE 386903B SE 7208742 A SE7208742 A SE 7208742A SE 874272 A SE874272 A SE 874272A SE 386903 B SE386903 B SE 386903B
Authority
SE
Sweden
Prior art keywords
beta
chlorine
procedure
preparation
substituted steroids
Prior art date
Application number
SE7208742A
Other languages
English (en)
Swedish (sv)
Inventor
G H Phillipps
L Stephenson
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of SE386903B publication Critical patent/SE386903B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
    • C07J7/0055Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7208742A 1968-01-29 1969-01-29 Forfarande for framstellning av beta-11-klorsubstituerade steroider tillhorande pregnanserien SE386903B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4570/68A GB1260465A (en) 1968-01-29 1968-01-29 11beta-CHLORO-19-NOR-STEROIDS

Publications (1)

Publication Number Publication Date
SE386903B true SE386903B (sv) 1976-08-23

Family

ID=9779640

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7208742A SE386903B (sv) 1968-01-29 1969-01-29 Forfarande for framstellning av beta-11-klorsubstituerade steroider tillhorande pregnanserien
SE01193/69A SE364267B (en, 2012) 1968-01-29 1969-01-29

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE01193/69A SE364267B (en, 2012) 1968-01-29 1969-01-29

Country Status (14)

Country Link
JP (2) JPS4828907B1 (en, 2012)
AT (1) AT309703B (en, 2012)
BE (1) BE727578A (en, 2012)
BR (1) BR6905985D0 (en, 2012)
CH (2) CH578017A5 (en, 2012)
DE (1) DE1904325C3 (en, 2012)
DK (1) DK128715B (en, 2012)
ES (1) ES363068A1 (en, 2012)
FR (1) FR2000924A1 (en, 2012)
GB (1) GB1260465A (en, 2012)
IE (1) IE33924B1 (en, 2012)
IL (1) IL31515A0 (en, 2012)
NL (1) NL6901342A (en, 2012)
SE (2) SE386903B (en, 2012)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52119945U (en, 2012) * 1976-03-08 1977-09-12
US5710293A (en) * 1995-10-13 1998-01-20 The Population Council, Center For Biomedical Research Method of preparation of ester derivatives of steroids

Also Published As

Publication number Publication date
AT309703B (de) 1973-08-27
BR6905985D0 (pt) 1973-04-19
CH592688A5 (en, 2012) 1977-11-15
GB1260465A (en) 1972-01-19
IE33924B1 (en) 1974-12-11
DE1904325B2 (de) 1978-02-16
ES363068A1 (es) 1971-06-16
CH578017A5 (en, 2012) 1976-07-30
IE33924L (en) 1969-07-29
SE364267B (en, 2012) 1974-02-18
JPS4828907B1 (en, 2012) 1973-09-05
FR2000924A1 (en, 2012) 1969-09-19
DK128715B (da) 1974-06-24
DE1904325C3 (de) 1978-10-26
IL31515A0 (en) 1969-03-27
NL6901342A (en, 2012) 1969-07-31
JPS4830051B1 (en, 2012) 1973-09-17
DE1904325A1 (de) 1969-09-04
BE727578A (en, 2012) 1969-07-29

Similar Documents

Publication Publication Date Title
IL31447A0 (en) Anti-inflammatory steroids of the pregnane series
SE381041B (sv) Forfarande for framstellning av aminoguanidiner
NL144588B (nl) Werkwijze ter bereiding van n-methylnitroanilinen.
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
IL33369A0 (en) Process for the preparation of steroids
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE397971B (sv) Forfarande for framstellning av halogenmetyl-1,3-polyhalogen-2-propyletrar
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
SE386903B (sv) Forfarande for framstellning av beta-11-klorsubstituerade steroider tillhorande pregnanserien
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE398232B (sv) Forfarande for framstellning av bensodiazepinderivat
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol
SE381876B (sv) Forfarande for framstellning av 19-nor-steroider
SE385694B (sv) Forfarande for framstellning av bisuretaner
SE343309B (sv) Foerfarande foer framstaellning av skumformiga etensampolymerisat
NL146811B (nl) Werkwijze ter bereiding van 5-benzylpyrimidinederivaten.
FI48347C (fi) Menetelmä 17beta-alkanoyylioksi-17alfa-propadienyyli-steroidien valmis tamiseksi.
SE343292B (sv) Foerfarande foer framstaellning av vissa angivna bensofenoniminer
NL143548B (nl) Werkwijze ter bereiding van alfa-sinensal.
SE382057B (sv) Forfarande for framstellning av n-hydroxialkylpiperazinylderivat
BR6912309D0 (pt) Novos derivados de 19-nor progesterona